Cases & Deals

Athersys issues $21 million of Common Stock in public offering

Clients Athersys, Inc.

Jones Day advised Athersys, Inc., a clinical stage biopharmaceutical company, in connection with the issuance of $21 million of Common Stock in a public offering, underwritten by Piper Jaffray & Co. and First Analysis Securities Corporation.